The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth
jetcityimage / iStock Editorial via Getty Images Lilly posted 53.9% revenue growth and 480% net income growth driven…
Johnson & Johnson announces deal to cut drug prices, new Pennsylvania manufacturing site | Berks Regional News
NEW BRUNSWICK, Nj. – Johnson & Johnson is the latest U.S. drugmaker to announce a deal with the…
Johnson & Johnson MedTech submits Ottava surgical robot to FDA
Johnson & Johnson MedTech (NYSE: JNJ) + announced today that it submitted its Ottava surgical robotic system to…
What may be driving Eli Lilly shares lower — plus, oil, financial stocks rally
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
2 Healthcare Stocks to Buy in a Bear Market
It might not seem like it, but the S&P 500 flirted with bear market territory earlier this year.…
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever
Bristol Myers Squibb is a pharmaceutical giant with a solid dividend history. Medtronic is a high-yield medical device…
Johnson & Johnson halts mid-stage trial of experimental eczema drug
Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
Stocks making the biggest moves premarket: NVO, HII, ZUN
Check out the companies making headlines before the bell. ZIM Integrated Shipping Services — The shipping services firm…
5 Dividends That Beat Social Security’s Unpredictable COLA Adjustments
24/7/ Wall St. Social Security COLA dropped from 8.7% in 2023 to 2.5% in 2025. Realty Income pays…
Jury awards $40M in case alleging Johnson’s Baby Power caused cancer
A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made…
5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right Now
24/7 Wall St Verizon offers the highest yield at 6.59% with a 0.32 beta and 19 consecutive years…
Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study
Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in. Johnson & Johnson (NYSE:JNJ) announced…